Your search returned 22 studies. (Get alerts for new studies):
- Blood and Tissue Collection for Cutaneous Lymphoma Research
Conditions: Cutaneous T-Cell Lymphoma - Sezary Syndrome - Mycosis Fungoides
1 Location available
- Topical Romidepsin in Treating Patients With Stage I or Stage II Cutaneous T-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
1 Location available
- Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
Conditions: Lymphoma - Bone Marrow Transplantation
1 Location available
- Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-H
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
Conditions: Cutaneous T-Cell Lymphoma
1 Location available
- Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
Conditions: Mycoses - Sezary Syndrome - Lymphoma, T-Cell, Cutaneous - Bone Marrow Transplant Failure - Lymphoma, Non-Hodgkin - Cutaneous T-cell Lymphoma of Skin
1 Location available
- Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma
Conditions: Stage I Cutaneous T-cell Non-Hodgkin Lymphoma - Stage I Mycosis Fungoides/Sezary Syndrome - Stage II Cutaneous T-cell Non-Hodgkin Lymphoma - Stage II Mycosis Fungoides/Sezary Syndrome - Stage III Cutaneous T-cell Non-Hodgkin Lymphoma - Stage III Mycosis F
1 Location available
- O6-Benzylguanine and Topical Carmustine in Early-Stage(IA-IIA) Cutaneous T-Cell Lymphoma
Conditions: Lymphoma
1 Location available
- Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)
Conditions: Refractory Cutaneous T-cell Lymphoma
17 Locations available
- Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Intraocular Lymp
1 Location available
- AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Conditions: Cutaneous T-cell Lymphoma - Mycosis Fungoides - Sezary Syndrome - Primary Cutaneous Anaplastic Large Cell Lymphoma
3 Locations available
- Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001
Conditions: Peripheral T-cell Lymphoma - Cutaneous T-cell Lymphoma
1 Location available
- SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Conditions: CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma - Lymphoma, Primary Cutaneous Anaplastic Large Cell - Lymphomatoid Papulosis - Mycosis Fungoides - Skin Lymphoma - Cutaneous Lymphomas - Lymphoma - Hematologic Disorder
1 Location available
- TLR8 Agonist VTX-2337 in Combo With Local Radiation in Low-Grade B-cell Lymphomas
Conditions: Lymphoma, Non-Hodgkin - Cutaneous Lymphoma - Large B Cell Diffuse Lymphoma - Mantle Cell Lymphoma - Marginal Zone B-Cell Lymphoma - Peripheral T-cell Lymphoma, Large Cell - Waldenstrom Macroglobulinemia
1 Location available
- Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Pro
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Hepatosplenic T-
1 Location available
- Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)
Conditions: Lymphoma, T-Cell, Cutaneous
4 Locations available
- Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma
Conditions: Mycosis Fungoides - Cutaneous T-Cell Lymphoma - Neoplasms
1 Location available
- Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
Conditions: Cutaneous T Cell Lymphoma - Graft Versus Host Disease
1 Location available
- A Study of the Histone Deacetylase Inhibitor (HDACi) JNJ-26481585 in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma (CTCL)
Conditions: Cutaneous T-cell Lymphoma; Histone Deacetylase Inhibitor; Lymphoma; Oncology
1 Location available
- A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell
Conditions: Primary Cutaneous Anaplastic Large Cell Lymphoma, - Mycosis Fungoides
1 Location available
|